Palomino, S.M.; Levine, A.A.; Liktor-Busa, E.; Tanguturi, P.; Streicher, J.M.; Largent-Milnes, T.M.
Brain Hsp90 Inhibition Mitigates Facial Allodynia in a Rat Model of CSD Headache and Upregulates Endocannabinoid Signaling in the PAG. Pharmaceuticals 2025, 18, 1430.
https://doi.org/10.3390/ph18101430
AMA Style
Palomino SM, Levine AA, Liktor-Busa E, Tanguturi P, Streicher JM, Largent-Milnes TM.
Brain Hsp90 Inhibition Mitigates Facial Allodynia in a Rat Model of CSD Headache and Upregulates Endocannabinoid Signaling in the PAG. Pharmaceuticals. 2025; 18(10):1430.
https://doi.org/10.3390/ph18101430
Chicago/Turabian Style
Palomino, Seph M., Aidan A. Levine, Erika Liktor-Busa, Parthasaradhireddy Tanguturi, John M. Streicher, and Tally M. Largent-Milnes.
2025. "Brain Hsp90 Inhibition Mitigates Facial Allodynia in a Rat Model of CSD Headache and Upregulates Endocannabinoid Signaling in the PAG" Pharmaceuticals 18, no. 10: 1430.
https://doi.org/10.3390/ph18101430
APA Style
Palomino, S. M., Levine, A. A., Liktor-Busa, E., Tanguturi, P., Streicher, J. M., & Largent-Milnes, T. M.
(2025). Brain Hsp90 Inhibition Mitigates Facial Allodynia in a Rat Model of CSD Headache and Upregulates Endocannabinoid Signaling in the PAG. Pharmaceuticals, 18(10), 1430.
https://doi.org/10.3390/ph18101430